F-1/A: MEDIROM Healthcare Technologies Inc. Files Amendment for Public Offering of American Depositary Shares

MEDIROM Healthcare Technologies Inc. has filed an amendment to its registration statement for a public offering of 1,661,130 American Depositary Shares, aiming to raise capital for working capital and general corporate purposes.

Summary

• MEDIROM Healthcare Technologies Inc. is conducting a public offering of 1,661,130 American Depositary Shares (ADS), each representing one common share.
• The company intends to use the net proceeds for working capital and general corporate purposes, including potential investments and acquisitions.
• The ADSs are listed on the Nasdaq Capital Market under the symbol MRM, with the last reported sale price at US$3.01 per ADS on November 26, 2024.
• The company is an emerging growth company and a foreign private issuer, which allows for reduced reporting requirements.
• The offering includes a 45-day option for underwriters to purchase up to 249,170 additional ADSs to cover over-allotments.
• The company operates three main segments: Relaxation Salon, Luxury Beauty, and Digital Preventative Healthcare.
• The Relaxation Salon segment is the core business, accounting for 88.8% of total revenue in 2023.
• The company aims to expand its Digital Preventative Healthcare segment, including its Lav application and MOTHER Bracelet.
• A strategic reorganization of the salon workforce mix is planned to increase the proportion of commission-based therapists.
• The company is also pursuing acquisitions in the domestic relaxation sector and expanding salons located at spa facilities.
• The company plans to acquire 70% of Japan Gene Medicine Corporation to expand its healthcare technology presence.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While there are positive aspects such as the company's brand strength, innovative services, and growth plans, there are also significant risks and challenges, including financial losses, high debt, and regulatory hurdles. The sentiment is neutral, leaning slightly negative due to the financial losses and risks.

Positives

• The company has a strong brand value and a loyal customer base.
• The company has a well-regarded training facility for relaxation therapists, Re.Ra.Ku College.
• The company offers innovative relaxation services, such as the wing stretch method.
• The company is well-positioned for growth in the Specific Health Guidance Program.
• The MOTHER Bracelet is a unique fitness tracker that requires no electric charging.
• The company is actively working to optimize its workforce and improve margins.
• The company is expanding its salon network through strategic acquisitions and new openings.
• The company is growing its Digital Preventative Healthcare segment through new products and services.

Negatives

• The company is geographically concentrated in the Tokyo metropolitan area.
• The Digital Preventative Healthcare segment has experienced delays in product development and release.
• The company is vulnerable to changes in consumer preferences and economic conditions.
• The company faces significant competition in the relaxation salon industry.
• The company has identified material weaknesses in its internal control over financial reporting.
• The company has a history of delays in complying with periodic reporting obligations.
• The company's CEO owns a golden share with key veto rights, limiting shareholder influence.
• The company has a high level of indebtedness.

Risks

• The company may not achieve its development goals, which could adversely affect operations and financial results.
• The company is implementing new growth strategies, and any inability to execute them could impact financial condition.
• Sales of salons to investors could vary from year to year, affecting annual revenue.
• The company may be adversely affected by Japanese and global economic conditions.
• The Digital Preventative Healthcare segment may not continue to grow or achieve profitability.
• The company's MOTHER Bracelet and Gateway may face component inflation.
• The company's system-wide relaxation salon base is geographically concentrated in the Tokyo metropolitan area.
• Past and future acquisitions may fail to deliver anticipated benefits.
• The planned acquisition of Japan Gene Medicine Corporation may not be completed.
• The company may not be able to maintain and enhance the value of its brands.
• The company may not be able to enforce and maintain its trademarks and protect its other intellectual property.
• The company may need to raise additional capital, which may be costly or difficult to obtain.
• The company's level of indebtedness could materially and adversely affect its business.
• The company depends on key members of its management and advisory team.
• The company may suffer losses from litigation or other claims.
• The company's prepaid cards are heavily regulated under Japanese law.
• The company may face labor shortages or increased labor costs.
• The company is subject to the risks associated with leasing space subject to long-term non-cancelable leases.
• The company is exposed to the risk of natural disasters, unusual weather conditions, pandemic outbreaks, political events, war and terrorism.
• The company is subject to foreign laws and regulations, and could be adversely affected by violations of these laws.
• There is a risk that the company will be a passive foreign investment company (PFIC), which could result in material adverse U.S. federal income tax consequences.
• The financial performance of the company's franchisees can negatively impact its business.
• The company has limited control with respect to the operations of its franchisees.
• The company is vulnerable to changes in consumer preferences and economic conditions.
• The company may not be able to compete successfully with other relaxation salon businesses.
• The company faces significant competition and continuous technological change.
• Information technology system failures or breaches of the company's network security could interrupt operations.
• The company is an emerging growth company and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies, its common shares and ADSs may be less attractive to investors.
• As a foreign private issuer, the company is permitted to follow certain home country corporate governance and other practices instead of otherwise applicable SEC and NASDAQ requirements.
• The company's ADSs are listed on the Nasdaq Capital Market, and the company must meet the Nasdaq Capital Markets continued listing requirements or risk delisting.
• The company may be, and has in the past been, delayed in complying with its periodic reporting obligations under the Exchange Act.
• The company's Chief Executive Officer owns a golden share with key veto rights, thereby limiting a shareholders ability to influence the company's business and affairs.
• The requirements of being a U.S. public company may strain the company's resources and divert managements attention.
• The company has identified material weaknesses in its internal control over financial reporting.
• The company is incorporated in Japan, and it may be more difficult to enforce judgments against the company that are obtained in courts outside of Japan.
• Substantially all of the company's revenues are generated in Japan, but an increase of its international presence could expose it to fluctuations in foreign currency exchange rates.
• Rights of shareholders under Japanese law may be different from rights of shareholders in other jurisdictions.
• The company's prepaid cards are heavily regulated under Japanese law and violations of the relevant law could subject the company to sanctions.
• The company is subject to various Japanese laws that may affect its relationship with its franchisees.
• The company is potentially subject to government regulations, and it may experience delays in obtaining required regulatory approvals, if required, to market its proposed businesses.
• The company may suffer losses from litigation or other claims, including if its services cause harm to customers.
• The company is exposed to the risk of natural disasters, unusual weather conditions, pandemic outbreaks such as COVID-19, political events, war and terrorism that could disrupt business and result in lower sales, increased operating costs and capital expenditures.
• The company depends on key members of its management and advisory team and will need to add and retain additional leading experts.
• The company is subject to the risks associated with leasing space subject to long-term non-cancelable leases.

Future Outlook

The company intends to use the net proceeds from this offering for working capital and general corporate purposes, which may include investments, acquisitions, or strategic collaborations to expand its customer base, as well as the development and marketing of new services. The company also plans to expand its Digital Preventative Healthcare segment and increase its profit margin.

Management Comments

• The company believes that its services are viewed as a more necessary item of consumer spending that they expect will increase demand for their services given the strength of their brand.
• The company anticipates that its planned acquisition of 70% of the equity of Japan Gene Medicine Corporation will provide opportunities for it to grow its presence in the healthcare technology space and expand the portfolio of services it offers to its relaxation salon clients.
• The company believes it can improve its margins at many of its salons by utilizing a greater proportion of commission-based therapists.
• The company aims to maximize the return on capital investment, accelerate salon openings by reinvesting the proceeds from the sales of salons, improve operational efficiency by further focusing on salon operations, and generate additional income from the salons that were sold to investors and are under its management.

Industry Context

The document indicates that the Japanese relaxation sector is experiencing consolidation, with smaller operators selling their businesses, which presents opportunities for larger players like MEDIROM. The company is also leveraging the growing consumer interest in personal health management and preventative care, particularly after the COVID-19 pandemic, to expand its Digital Preventative Healthcare segment.

Comparison to Industry Standards

• The document states that MEDIROM is one of the top three companies in the Kanto region and top four nationwide in terms of the number of relaxation salons, according to the 2022 Yano Report.
• The largest operator in the Japanese relaxation sector has 613 salons, while MEDIROM aims to operate 500 salons by the end of 2028.
• The company's mid-term business plan goal is to operate 500 salons on a system-wide basis by the end of 2028.
• The company's MOTHER Bracelet is described as the only fitness tracker that requires no electric charging, giving it a competitive edge.
• The company's Re.Ra.Ku College is described as one of the largest and best in-class education and training facilities for relaxation therapists in the Japanese relaxation industry.
• The company's relaxation services are described as innovative and different from traditional shiatsu-style bodywork, using stretch techniques rather than pressure.

Related Party Transactions

• The company has a Trademark License Agreement with its CEO, Kouji Eguchi.
• The company has consulting agreements with companies owned by its independent directors, Akira Nojima and Tomoya Ogawa.
• The company has a consulting agreement with a company where its corporate auditor, Osamu Sato, is a part-time employee.
• The company's CEO, Kouji Eguchi, is a guarantor for some of the company's borrowings.
• The representative director of ZACC, Kazuyoshi Takahashi, is a guarantor for some of ZACC's borrowings.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares in this offering and through the conversion of convertible bonds.
• Employees may benefit from the company's focus on employee satisfaction and career progression.
• Customers may benefit from the company's innovative services and expansion of its salon network.
• Franchisees may benefit from the company's support and training programs.
• Suppliers may benefit from the company's growth and expansion.

Next Steps

• The company plans to continue to expand its salon network through strategic acquisitions and new openings.
• The company plans to continue to grow its Digital Preventative Healthcare segment through new products and services.
• The company plans to complete the acquisition of 70% of Japan Gene Medicine Corporation.
• The company plans to continue to optimize its workforce and improve margins.
• The company plans to continue to seek attractive financing opportunities for its Digital Preventative Healthcare business.

Key Dates

Keywords

relaxation salons, healthcare technology, digital preventative healthcare, MOTHER Bracelet, franchise, Japan, public offering, ADS, wellness, beauty